$1.10
-0.01-0.90%
In chiusura: -
$1.13
0.032.73%
After hour: Nov 14, 5:39 PM EDT
Comments
Loading...
Attività di insider trading
Tieni traccia delle ultime attività di insider trading Heron Therapeutics. Rimani informato sui recenti acquisti, vendite e impatto sul mercato per le azioni Heron Therapeutics.
Cos'è l'attività interna?
L'attività di insider trading coinvolge soggetti interni all'azienda, come dirigenti, direttori e dipendenti, impegnati in transazioni sulle azioni della propria azienda. Le transazioni di acquisto e vendita degli addetti ai lavori forniscono informazioni preziose sulla loro fiducia nelle prestazioni future dell'azienda.
Cosa stanno facendo gli Heron Therapeutics Inc addetti ai lavori?
Gli addetti ai lavori non hanno segnalato acquisti/vendite negli ultimi 30 giorni.
Notevoli acquisti e vendite recenti di insider
Non ci sono stati acquisti o vendite da parte di Insider negli ultimi 90 giorni.
Statistiche sulla proprietà per Heron Therapeutics Inc
Numero di azioni emesse
183.314M
Azioni possedute dagli insider
3.184M
Percentuale posseduta dagli Insider
1.74%
Azioni possedute dagli investitori istituzionali
38.226M
Percentuale posseduta dagli investitori istituzionali
20.8%
Aug 12, 2025 | DIRECTOR | 1.77M | $1.50 | $2.65M | BUY | 25.03% | 8.82M | Aug 08 | ||
Nov 21, 2023 | EVP, CHIEF DEVELOPMENT OFFICER | 25.00K | $1.09 | $27.25K | BUY | 46.30% | 79.00K | Nov 17 | ||
Nov 20, 2023 | EVP, CHIEF DEVELOPMENT OFFICER | 50.00K | $0.94 | $46.99K | BUY | 1250.00% | 54.00K | Nov 16 | ||
Nov 17, 2023 | CHIEF EXECUTIVE OFFICER | 150.00K | $0.92 | $137.97K | BUY | 411.00% | 186.50K | Nov 16 | ||
Nov 17, 2023 | EVP, CHIEF FINANCIAL OFFICER | 85.00K | $0.89 | $75.60K | BUY | ∞ | 85.00K | Nov 16 | ||
Jul 25, 2023 | DIRECTOR | 2.49M | $1.37 | $3.41M | BUY | 54.80% | 7.02M | Jul 21 | ||
May 04, 2022 | EVP, DRUG DEVELOPMENT | 0.00 | $4.30 | -$1.38K | ACQ/DIS | 0.00% | 10.87K | Apr 29 - May 03 | ||
Dec 23, 2021 | DIRECTOR | 10.15K | $9.73 | -$2.92K | GRANT | 290.06% | 13.65K | Dec 21 - Dec 22 | ||
Dec 23, 2021 | DIRECTOR | 10.20K | $9.73 | -$2.43K | GRANT | 330.16% | 13.29K | Dec 21 - Dec 22 | ||
Sep 23, 2021 | DIRECTOR | -300.00 | $12.31 | -$3.69K | SELL | -7.89% | 3.50K | Sep 21 | ||
Sep 23, 2021 | DIRECTOR | -250.00 | $12.30 | -$3.07K | SELL | -7.49% | 3.09K | Sep 21 | ||
Jun 22, 2021 | DIRECTOR | -300.00 | $15.20 | -$4.56K | SELL | -7.32% | 3.80K | Jun 21 | ||
Jun 22, 2021 | DIRECTOR | -250.00 | $15.20 | -$3.80K | SELL | -6.96% | 3.34K | Jun 21 | ||
May 04, 2021 | EVP, DRUG DEVELOPMENT | 0.00 | $15.78 | -$5.76K | ACQ/DIS | 0.00% | 1.63K | Apr 30 - May 03 | ||
Apr 16, 2021 | DIRECTOR | -300.00 | $17.51 | -$5.25K | SELL | -6.82% | 4.10K | Apr 15 | ||
Apr 07, 2021 | DIRECTOR | -250.00 | $17.22 | -$4.31K | SELL | -6.51% | 3.59K | Apr 06 | ||
Jan 15, 2021 | EVP, CHIEF OPERATING OFFICER | 0.00 | $18.11 | -$22.64K | SELL-OPTIONS | 0.00% | 0.00 | Jan 13 - Jan 14 | ||
Jan 08, 2021 | EVP, CHIEF OPERATING OFFICER | -3.57K | $19.66 | -$70.22K | SELL | -100.00% | 0.00 | Jan 08 | ||
Dec 23, 2020 | — | 0.00 | $16.50 | -$70.00K | OPTION EXERCISE | 0.00% | 0.00 | Dec 22 | ||
May 01, 2020 | — | 0.00 | $13.04 | -$2.14K | ACQUISITION OR DISPOSITION | 0.00% | 0.00 | Apr 30 - May 01 | ||
Dec 03, 2019 | EXECUTIVE VP, DRUG DEVELOPMENT | 0.00 | $19.50 | -$312.00K | SELL-OPTIONS | 0.00% | 0.00 | Nov 29 | ||
Oct 07, 2019 | DIRECTOR | 285.71K | $17.50 | $5.00M | BUY | 5.18% | 5.81M | Oct 04 | ||
Oct 04, 2019 | CHIEF EXECUTIVE OFFICER | 5.38K | $17.64 | $94.85K | BUY | 6.02% | 94.65K | Apr 30 - Oct 03 | ||
Oct 04, 2019 | EVP, CHIEF COMMERCIAL OFFICER | 5.14K | $17.50 | $90.00K | BUY | 39.56% | 18.14K | Oct 03 | ||
May 23, 2019 | DIRECTOR | 3.00K | $17.55 | $52.65K | BUY | 30.00% | 13.00K | May 22 | ||
May 16, 2019 | DIRECTOR | 1.40K | $18.04 | $25.26K | BUY | ∞ | 1.40K | May 15 | ||
May 02, 2019 | EXECUTIVE VP, DRUG DEVELOPMENT | 0.00 | $18.65 | -$481.42 | ACQ/DIS | 0.00% | 0.00 | Apr 30 - May 01 | ||
Nov 02, 2018 | EXECUTIVE VP, DRUG DEVELOPMENT | 0.00 | $27.11 | -$3.47K | ACQ/DIS | 0.00% | 0.00 | Oct 31 - Nov 02 | ||
Oct 02, 2018 | EXECUTIVE VP, DRUG DEVELOPMENT | 0.00 | $22.54 | -$114.43K | SELL-OPTIONS | 0.00% | 0.00 | Oct 01 | ||
Sep 12, 2018 | DIRECTOR | -2.69M | $35.75 | -$96.35M | SELL | -31.59% | 5.84M | Sep 12 | ||
Jul 03, 2018 | EXECUTIVE VP, DRUG DEVELOPMENT | 0.00 | $25.26 | -$147.18K | SELL-OPTIONS | 0.00% | 0.00 | Jul 02 | ||
Jul 03, 2018 | CFO & SVP, FINANCE | 744.00 | $26.71 | -$676.40K | SELL-OPTIONS | 138.81% | 1.28K | Apr 30 - Jul 02 | ||
Jul 03, 2018 | PRESIDENT | 0.00 | $23.09 | -$7.15M | SELL-OPTIONS | 0.00% | 2.64K | Jun 29 - Jul 02 | ||
Jun 22, 2018 | CHIEF EXECUTIVE OFFICER | 1.61K | $24.11 | -$1.48M | SELL-OPTIONS | 2.36% | 69.60K | Apr 30 - Jun 21 | ||
Apr 02, 2018 | DIRECTOR | 192.31K | $26.00 | $5.00M | BUY | 2.31% | 8.53M | Mar 29 | ||
Mar 19, 2018 | EXECUTIVE VP, DRUG DEVELOPMENT | 0.00 | $21.50 | -$306.00K | SELL-OPTIONS | 0.00% | 0.00 | Mar 19 | ||
Mar 19, 2018 | CHIEF EXECUTIVE OFFICER | 0.00 | $18.48 | -$2.25M | SELL-OPTIONS | 0.00% | 67.99K | Mar 19 | ||
Mar 16, 2018 | CHIEF EXECUTIVE OFFICER | 0.00 | $15.97 | -$1.75M | SELL-OPTIONS | 0.00% | 67.99K | Mar 14 | ||
Jan 12, 2018 | EXECUTIVE VP, DRUG DEVELOPMENT | 0.00 | $16.50 | -$53.09K | SELL-OPTIONS | 0.00% | 0.00 | Jan 10 | ||
Apr 24, 2017 | EXECUTIVE VP, DRUG DEVELOPMENT | 0.00 | $12.16 | -$136.62K | SELL-OPTIONS | 0.00% | 0.00 | Apr 24 | ||
Jan 23, 2017 | DIRECTOR | 10.00K | $12.20 | $122.00K | BUY | ∞ | 10.00K | Jan 19 | ||
Jan 23, 2017 | DIRECTOR | 2.46M | $12.20 | $30.00M | BUY | 41.81% | 8.34M | Jan 19 | ||
Aug 12, 2016 | PRESIDENT & CCO | 0.00 | $15.25 | -$1.61M | SELL-OPTIONS | 0.00% | 2.64K | Aug 10 | ||
Apr 21, 2016 | PRESIDENT | 0.00 | $15.22 | -$3.21M | SELL-OPTIONS | 0.00% | 2.64K | Apr 19 - Apr 21 | ||
Jun 12, 2015 | DIRECTOR | 121.21K | $24.75 | $3.00M | BUY | 2.55% | 4.87M | Jun 10 | ||
Jun 03, 2015 | DIRECTOR | 0.00 | $15.97 | -$188.01K | SELL-OPTIONS | 0.00% | 0.00 | Jun 01 - Jun 02 | ||
Jun 02, 2015 | DIRECTOR | 150.00K | $20.62 | $3.09M | BUY | 3.26% | 4.75M | May 29 - Jun 02 | ||
Mar 09, 2015 | SVP, TECHNICAL OPERATIONS | 0.00 | $12.04 | -$370.00K | SELL-OPTIONS | 0.00% | 0.00 | Mar 05 | ||
Mar 04, 2015 | CHIEF EXECUTIVE OFFICER | -10.00K | $13.07 | -$130.73K | SELL | -18.92% | 42.87K | Mar 02 | ||
Jun 27, 2014 | DIRECTOR | 510.64K | $11.75 | $6.00M | BUY | 12.48% | 4.60M | Jun 25 | ||
Jun 26, 2014 | CHIEF EXECUTIVE OFFICER | 10.00K | $11.75 | $117.50K | BUY | 19.28% | 61.85K | Jun 25 |
FAQ
L'insider trading è legale?
L'insider trading è legale a condizione che gli insider segnalino le loro operazioni alla SEC. Il trading illegale di titoli si verifica quando l'insider viola un dovere fiduciario o non segnala le sue operazioni.
Quali sono alcuni esempi di manipolazione del mercato?
L'insider trading, gli schemi di pump and dump, il front running e i wash trade sono tutti esempi di manipolazione del mercato. Gli investitori che seguono i movimenti delle attività degli insider dovrebbero riflettere attentamente sul motivo per cui questi insider stanno negoziando le loro azioni prima di procedere.
Sfoglia insider trading su tutte le azioni.